Werewolf Therapeutics, Inc. (HOWL) Q1 2025 Earnings
HOWL·Reported May 8, 2025·Before market open
Diluted EPS came in at $-0.40 (-2.6% YoY), beat the $-0.44 consensus by $0.04.
Diluted EPS
$-0.40beat by $0.04
Consensus: $-0.44
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Werewolf Therapeutics, Inc.'s Q1 2025 earnings report.
Werewolf Therapeutics, Inc. (HOWL) reported Q1 2025 earnings on May 8, 2025 before market open.
Werewolf Therapeutics, Inc. reported diluted EPS of $-0.40 for Q1 2025.
EPS beat the consensus estimate of $-0.44 by $0.04.
Compared to the same quarter a year prior, diluted EPS declined 2.6% from $-0.39.
You can read the 10-Q periodic report (0001785530-25-000014) directly on SEC EDGAR. The filing index links above go to sec.gov.